Chronic kidney failure may be due to diabetes or low blood sugar, and affects approximately 2 million people. In the US, kidney disease affects over 2 out of every 1,000 people. In kidney dialysis, a machine called a dialyzer uses a solution to clean the blood. Products used in this process were GranuFlo and NaturaLyte, which may produce an excess of bicarbonate leading to a condition known as metabolic alkalosis in which pH levels in the body are elevated. This condition can cause low blood pressure, heart attacks, serious heart injuries and sudden cardiac-related deaths.
GranuFlo and NaturaLyte are manufactured and marketed by Fresenius Medical Care (FMC). IN 2011, Fresenius had a whopping net revenue of $12.8 billion and is the US leader in the dialysis market. FMC also owns over 1,800 U.S. Dialysis clinics that perform these treatments with GranuFlo. Additionally, approximately 125,000 patients are treated with GranuFlo at other clinics.
At the present time, Fresenius Medical Care has numerous suits against it since 941 patients suffered from cardiac arrest in 2010 after being treated with GranuFlo products. In March of 2012, the FDA recalled both GranuFlo and NaturaLyte. Unfortunately, this recall came far too late to save countless patients who experienced severe symptoms or died from these products. Worst of all, patients or survivors of loved ones who died say they were not informed of the dangers of using GranuFlo or NaturaLyte.